Here are three details:
1. Proceeds of the financing will go toward the expansion and clinical development of Providence’s DTRAX line of cervical fusion instruments.
2. The DTRAX Spinal System has been installed at more than 1,800 U.S. hospitals.
3. Revelation Partners, BMO Global Asset Management, MVM Life Science Partners, Medvest Capital and Aphelion Capital contributed to the financing.
More articles on devices:
Medtronic, Zimmer Biomet, Smith & Nephew & more: 15 device company notes
18 spine devices received FDA 510(k) clearance in August
Medtronic joins initiative to bring more women into board seats
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
